Nara, Japan

Masato Terakawa


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masato Terakawa: Innovator in Pharmaceutical Composition

Introduction

Masato Terakawa is a notable inventor based in Nara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating various medical conditions. With a total of 2 patents to his name, Terakawa's work has the potential to impact many lives.

Latest Patents

Terakawa's latest patents include a diuretic or antihypertensive composition. This invention provides a method for treating edema or hypertension by administering an effective amount of a quinazoline derivative. The general formula involves components where R¹, R², and R³ can be hydrogen atoms, halogen atoms, or pharmaceutically acceptable salts. Another significant patent is a uricosuric composition aimed at preventing and/or treating gout and hyperuricemia. This method also utilizes a quinazoline derivative of a similar general formula to provide effective treatment.

Career Highlights

Masato Terakawa is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been able to apply his innovative ideas in a professional setting. His work at this esteemed company has allowed him to focus on developing pharmaceutical solutions that address critical health issues.

Collaborations

Throughout his career, Terakawa has collaborated with notable colleagues, including Mitsuyoshi Nakashima and Mitsutaka Kanamaru. These collaborations have likely contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Masato Terakawa's contributions to pharmaceutical compositions demonstrate his commitment to innovation in healthcare. His patents reflect a deep understanding of medical needs and a dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…